The Great Indian Biologics Festival 2025 is a great venue for life sciences community to come together to bridge the gap between R&D, process development, and bioprocessing of vaccines and biologics for emerging markets.
The 12th Annual Biologics Manufacturing Asia 2025 is a renowned bioprocessing conference that provides a forum for regional biopharmaceutical players to discuss cutting-edge manufacturing technology and potential partnerships. The program includes insights from global pharmaceutical corporations as well as success stories from biopharmaceutical companies in Asia. Innovations in single-use and continuous processing, biomanufacturing prospects and problems, improvements in upstream process development, downstream processing cost optimization, analytical techniques, facility design, and fill & finish innovations are among the topics covered.
In order to improve networking and educational possibilities, this year's event is co-located with the 9th Annual Biologistics World Asia 2025, 3rd Clinical Trial Festival Asia 2025, and the Asia-Pacific Bioprocessing Excellence Awards Gala Dinner 2025.
Because of the protracted approval processes, generic competition, growing costs, and difficulties with adherence, the drug development model is in dire need of reform. Now in its eleventh year, the 2025 Controlled & Modified Drug Release Summit provides a critical dose of innovation to address these concerns. Attendees will study innovative case studies, hear from top experts, and discover the newest techniques and technology for improving medication release mechanisms and cutting time-to-market. The most recent regulatory revisions and their effects on industry will also be discussed during the conference. This June, explore cutting-edge formulation and delivery technologies in Princeton, NJ, with over 160 senior drug development professionals in attendance. Sign up now to receive game-changing tactics that might shorten time to market and save millions of dollars.
